Click the link above to access PDF slides pertaining to my cannabis talk for the Hemp and Health Expo at the Trac Center in Pasco, WA. on Saturday, November 14th. Topics discussed include how the toxicity of conventional pain drugs compares with cannabis, the endocannabinoid system, how to use synergy in plant medicine to maximize the use of medical cannabis, as well as sections on cannabis and pain and neurological disorders. A YouTube video will be recorded and posted later as well.
Click the link above to access PDF slides pertaining to my cannabis talk for the Seattle Dystonia Support Group at Evergreen Hospital. Topics discussed include how the toxicity of conventional pain drugs compares with cannabis, the endocannabinoid system, how to use synergy in plant medicine to maximize the use of medical cannabis, as well as sections on cannabis and pain and neurological disorders. A YouTube video will be recorded and posted later as well.
No other pain relieving medication is less toxic than cannabis, not even aspirin or Tylenol. If deaths from toxic effects from NSAIDs such as ibuprofen and Aleve were tabulated separately in the National Vital Statistics reports, these drug toxicities would constitute the 15th most common cause of death in the United States. This is why cannabis as medicine can be an excellent choice as a substitute for more toxic pain killers. As patients become more attuned to the benefits of cannabis as an inexpensive natural pain reliever that doesn’t have death as a side-effect, many forward thinking doctors are recognizing the amazing benefits of low-toxic cannaibis for pain and inflammation.
The July 1998 issue of The American Journal of Medicine stated the following: “Conservative calculations estimate that approximately 107,000 patients are hospitalized annually for nonsteroidal anti-inflammatory drug (NSAID)-related gastrointestinal (GI) complications and at least 16,500 NSAID-related deaths occur each year among arthritis patients alone. The figures of all NSAID users would be overwhelming, yet the scope of this problem is generally under-appreciated.” Medical cannabis has never killed a single patient.
And again in June 1999 the prestigious New England Journal of Medicine issued a similar statement: “It has been estimated conservatively that 16,500 NSAID-related deaths occur among patients with rheumatoid arthritis or osteoarthritis every year in the United States. This figure is similar to the number of deaths from the acquired immunodeficiency syndrome and considerably greater than the number of deaths from multiple myeloma, asthma, cervical cancer, or Hodgkin’s disease. If deaths from gastrointestinal toxic effects from NSAIDs were tabulated separately in the National Vital Statistics reports, these effects would constitute the 15th most common cause of death in the United States. Yet these toxic effects remain mainly a “silent epidemic,” with many physicians and most patients unaware of the magnitude of the problem. Furthermore the mortality statistics do not include deaths ascribed to the use of over-the-counter NSAIDS.” Again, medical cannabis has never killed a single patient.
A recent study in Therapeutics and Clinical Risk Management notes that the number of deaths and hospitalizations from GI bleeding due to NSAIDs has remained unchanged since the 1999 study.
“From 1999 to 2007, the number of U.S. poisoning deaths involving any opioid analgesic (e.g., oxycodone, methadone, or hydrocodone) more than tripled, from 4,041 to 14,459, or 36% of the 40,059 total poisoning deaths in 2007. In 1999, opioid analgesics were involved in 20% of the 19,741 poisoning deaths. During 1999–2007, the number of poisoning deaths involving specified drugs other than opioid analgesics increased from 9,262 to 12,790, and the number involving nonspecified drugs increased from 3,608 to 8,947.”http://www.cdc.gov/mmwr/pdf/wk/mm5932.pdf
The use of cannabis to treat pain is intelligent medicine. Let the healing begin….
“Marijuana, in it’s natural form, is one of the safest therapeutically active substances known to man … One must reasonably conclude that there is accepted safety for use of marijuana under medical supervision. To conclude otherwise, on the record, would be unreasonable, arbitrary, and capricious” – DEA Administrative Law Judge Francis J. young, 1988